Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic targetMelanie Weingart, Eric H. Raabe, Jacquelyn J. Roth et al.|Oncotarget|2014Cited by 85
Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastomaAllison R. Hanaford, Eric H. Raabe, Jesse Alt et al.|Translational Oncology|2019Cited by 74
The dual mTOR kinase inhibitor TAK228 inhibits tumorigenicity and enhances radiosensitization in diffuse intrinsic pontine gliomaHiroaki Miyahara, Eric H. Raabe, Javad Nazarian et al.|Cancer Letters|2017Cited by 68
The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastomaHarpreet Kaur, Eric H. Raabe, Sabeen Z. Ali et al.|Cancer Letters|2016Cited by 60
Pediatric Brain Tumors: Current Knowledge and Therapeutic OpportunitiesJohn Glod, Mark A. Israel, Gilbert J. Rahme et al.|Journal of Pediatric Hematology/Oncology|2016Cited by 37